Michael Berman is a medical device investor/entrepreneur who serves on the boards of 11 emerging medical companies:
ClearCut Medical http://www.clrcut.com
QArt Medical https://www.qart-medical.com
RiverVest Ventures Venture Partner/Consultant since 2014
Mr. Berman was a co-founder of Velocimed which was sold to
St. Jude Medical
in April, 2005 for $82.5M.
Mr. Berman was a Director of Lutonix from 2007 until 2011 when it was sold to CR Bard for $225M, plus $100M upon FDA approval.
Mr. Berman was a co-founder and Chairman of BridgePoint Medical from 2005 till 2012 when it was sold to Boston Scientific.
Mr. Berman was a co-founder and Chairman of Rebiotix from 2011 till 2018 when it was sold to Ferring Pharmaceuticals.
Mr. Berman was a board member of Mazor Robotics from 2014 till 2018 when it was acquired by Medtronic for $1.7 Billion
Mr. Berman was a director of UltraShape inc. from 2005 till 2011 when it was sold to Syneron.
From 1995-2000 Mr. Berman was the President of the Cardiology business of
Cornell University, BS, 1979
Cornell University, MBA, 1986
Michael Berman Inducted into the Minnesota Business Hall of Fame
Read About Michael Berman in Twin Cities Business Monthly
Read About Michael Berman in MN Business Magazine
Tel Aviv, 64044 Israel
Israel Mobile: +972-52-420-3064
USA VOIP : +1-952-512-1523